Related Experiment Video
Updated: Jan 7, 2026

Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery
Published on: June 28, 2019
Angiotensin receptor conformations stabilized by biased ligands differentially modulate β-arrestin interactions
Matthias Elgeti1, Julia Belyaeva2, Mahdi Bagherpoor Helabad3
1Institute for Drug Discovery and Institute for Medical Physics and Biophysics, University of Leipzig Medical School, Leipzig, Germany; Integrative Center for Bioinformatics, University of Leipzig, Leipzig, Germany.
None:
"Biased" ligands of the angiotensin II type 1 receptor (AT1R) preferentially activate G protein or β-arrestin pathways by stabilizing distinct receptor conformations. Here, we show that β-arrestin-biased AT1R ligands vary in their ability to stabilize different modes of β-arrestin interaction, specifically interactions with the AT1R seven-transmembrane core versus the phosphorylated C-terminus. By combining biochemical assays with double electron-electron resonance spectroscopy and integrative modeling, we show that ligands less effective at stabilizing the core complex promote an AT1R conformation with an intermediate transmembrane helix six position that is incompatible with β-arrestin core binding. Since interactions with the core and phosphosites of G protein-coupled receptors (GPCRs) differentially activate the signaling, internalization, and desensitization functions of β-arrestin, our data demonstrate that the allosteric effects of GPCR ligands could directly modulate β-arrestin activities. This "intra-transducer bias," or bias toward various functions of the same transducer, could enable finer control of GPCR drug pharmacology than previously thought possible.
More Related Videos
09:51Live Cell Imaging and 3D Analysis of Angiotensin Receptor Type 1a Trafficking in Transfected Human Embryonic Kidney Cells Using Confocal Microscopy
Published on: March 27, 2017
09:03Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay
Published on: March 10, 2020
Related Concept Videos
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
The Two-State Receptor Model
The binding affinity of a drug determines its interaction with...
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Antihypertensive Drugs: Action of β1 Blockers
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...